Median effective dose of nefopam to treat postoperative pain in patients who have undergone laparoscopic cholecystectomy

The Journal of International Medical Research
Heezoo KimMido Lee

Abstract

Objective Nefopam is thought to reduce postoperative pain; however, the evidence is insufficient. The recommended dose is 20 mg, and the median effective dose (ED50) in the surgical setting reportedly ranges from 17 to 28 mg. However, nefopam frequently produces inadequate postoperative analgesia. We evaluated the ED50 of nefopam as a single agent in patients undergoing laparoscopic cholecystectomy. Methods Twenty-nine patients were scheduled for laparoscopic cholecystectomy. Postoperative pain was evaluated using a numerical pain scale (NPS). When the NPS score was >3, patients were administered a predetermined dose of nefopam. The dose was calculated using the up-and-down allocation technique based on the previous response. The initial dose was 28 mg, with adjustment intervals of 5 mg. An effective response was defined as a decrease in the NPS score to <3 at 30 minutes after infusion. Results The ED50 of nefopam was 62.1 mg (95% confidence interval, 52.9-72.9 mg). Eight patients reported pain upon injection, and three were excluded due to severe injection pain and phlebitis. Conclusions The estimated ED50 was higher than the predetermined dose based on previous studies. We recommend that the dose of nefopam be chosen after ca...Continue Reading

References

Nov 1, 1975·Clinical Pharmacology and Therapeutics·A Sunshine, E Laska
Jan 1, 1991·Neuroscience and Biobehavioral Reviews·W J Dixon
Sep 11, 1981·European Journal of Pharmacology·M F Piercey, L A Schroeder
Feb 1, 1981·British Journal of Clinical Pharmacology·A M BhattS E Maddison
Jun 6, 1981·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
Apr 1, 1999·Journal of Pharmacological and Toxicological Methods·A H Lichtman
Nov 25, 2003·British Journal of Anaesthesia·B Du ManoirD Fletcher
Dec 24, 2003·European Journal of Anaesthesiology·G TramoniK Bhageerutty
Nov 5, 2004·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Brid McGrathShirley King
Jan 22, 2005·Annales Françaises D'anesthèsie Et De Rèanimation·J C MerleN Nathan
Jun 21, 2007·British Journal of Clinical Pharmacology·Hélène BeloeilJean-Xavier Mazoit
Sep 18, 2008·British Journal of Anaesthesia·M S EvansM R Tramèr
Jan 6, 2011·British Journal of Anaesthesia·G ChanquesS Jaber
Apr 23, 2016·The Korean Journal of Pain·Jee Youn MoonSo Hyun Lee
Jun 24, 2017·International Journal of Medical Sciences·Eun Mi KimMi Hyeon Lee

❮ Previous
Next ❯

Software Mentioned

GraphPad Prism

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.